Select Medical Holdings (SEM) Cash & Equivalents (2018 - 2026)

Select Medical Holdings (SEM) has 9 years of Cash & Equivalents data on file, last reported at $25.7 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $25.7 million, down 51.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.7 million (down 51.74% YoY), and the FY2025 annual result was $26.5 million, down 55.57% from the prior year.
• Cash & Equivalents fell to $25.7 million in Q1 2026 per SEM's latest filing, from $26.5 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $191.5 million in Q3 2024 and troughed at $25.7 million in Q1 2026.
• A 5-year average of $83.5 million and a median of $83.7 million in 2023 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2024: Cash & Equivalents sank 88.22% in 2022, then surged 147.25% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $97.9 million in 2022, then tumbled by 46.24% to $52.6 million in 2023, then increased by 13.42% to $59.7 million in 2024, then slumped by 55.57% to $26.5 million in 2025, then fell by 3.17% to $25.7 million in 2026.
• Business Quant data shows SEM's Cash & Equivalents at $25.7 million in Q1 2026, $26.5 million in Q4 2025, and $60.1 million in Q3 2025.